This study had some limitations that need to be acknowledged
A longer follow-up period might provide better discernment of differences in HCRU, and this should be considered for future studies
Understanding these factors with your provider can refine your dosing strategy and improve adherence
Multiplex single-cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer
Nearly 6 out of 10 participants taking the 12 mg dose, specifically 58.6%, lost at least 25% of their body weight
13 Relevant factors can include: The claims made directly or indirectly The intended purpose The route by which the product is intended to be used The product format and packaging Its known pharmacological properties Website imagery and customer testimonials Instructions provided with the product A topical cosmetic and a product presented for injection are not interchangeable regulatory categories
